Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

LH

Labcorp Holdings Inc

Dec 13 • 04:00PM ET

232.01

Dollar change +0.17
Percentage change 0.07	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: DGX NEO OPK ICLR QDEL AVTR

| Held by: VTI VOO VO SPY IVV VTV RSP XLV VOE IWR

Scroll to Statements

Index	S&P 500	P/E	44.92	EPS (ttm)	5.16	Insider Own	0.34%	Shs Outstand	83.70M	Perf Week	-0.24%
Market Cap	19.42B	Forward P/E	14.48	EPS next Y	16.02	Insider Trans	-16.11%	Shs Float	83.35M	Perf Month	-5.77%
Income	435.50M	PEG	5.37	EPS next Q	3.39	Inst Own	93.62%	Short Float	2.37%	Perf Quarter	2.77%
Sales	12.71B	P/S	1.53	EPS this Y	7.07%	Inst Trans	-1.59%	Short Ratio	3.34	Perf Half Y	16.07%
Book/sh	97.61	P/B	2.38	EPS next Y	10.35%	ROA	2.45%	Short Interest	1.97M	Perf Year	4.76%
Cash/sh	18.13	P/C	12.80	EPS next 5Y	8.37%	ROE	5.43%	52W Range	191.97 - 247.99	Perf YTD	2.08%
Dividend Est.	2.91 (1.25%)	P/FCF	23.03	EPS past 5Y	-11.14%	ROI	3.05%	52W High	-6.44%	Beta	1.06
Dividend TTM	2.88 (1.24%)	Quick Ratio	1.30	Sales past 5Y	2.87%	Gross Margin	25.99%	52W Low	20.86%	ATR (14)	4.54
Dividend Ex-Date	Nov 26, 2024	Current Ratio	1.44	EPS Y/Y TTM	-30.81%	Oper. Margin	8.94%	RSI (14)	45.25	Volatility	2.13% 1.94%
Employees	67000	Debt/Eq	0.94	Sales Y/Y TTM	-6.13%	Profit Margin	3.43%	Recom	1.70	Target Price	265.19
Option/Short	Yes / Yes	LT Debt/Eq	0.75	EPS Q/Q	-4.79%	Payout	60.36%	Rel Volume	0.54	Prev Close	231.84
Sales Surprise	0.65%	EPS Surprise	0.79%	Sales Q/Q	7.37%	Earnings	Oct 24 BMO	Avg Volume	591.24K	Price	232.01
SMA20	-2.13%	SMA50	0.79%	SMA200	7.07%	Trades		Volume	318,477	Change	0.07%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	Jefferies	Buy	$265 → $275
Oct-30-24	Upgrade	HSBC Securities	Hold → Buy
Oct-01-24	Initiated	Piper Sandler	Neutral	$235
Mar-25-24	Upgrade	Argus	Hold → Buy	$250
Feb-26-24	Initiated	Leerink Partners	Outperform	$260
Feb-09-24	Initiated	Evercore ISI	In-line	$240
Jan-03-24	Initiated	Barclays	Equal Weight	$222
Sep-06-23	Initiated	HSBC Securities	Hold	$210
Dec-12-22	Downgrade	Citigroup	Buy → Neutral	$275 → $250
Sep-19-22	Downgrade	Argus	Buy → Hold
Aug-22-22	Resumed	Morgan Stanley	Overweight	$300
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold	$330 → $294
Jan-11-21	Upgrade	Argus	Hold → Buy	$245
Jan-11-21	Downgrade	Wolfe Research	Peer Perform → Underperform
Jan-08-21	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-14-20	Upgrade	BofA Securities	Neutral → Buy	$194 → $220
Jul-13-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-02-20	Resumed	Deutsche Bank	Buy	$210
May-15-20	Upgrade	Mizuho	Neutral → Buy	$158 → $186
Apr-29-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight

Show Previous Ratings

Dec-12-24 05:00AM	Labcorp closes takeover of Ballad Health outreach laboratory services (MedTech Dive)
Nov-26-24 08:05AM	Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients (PR Newswire)
Nov-19-24 07:00AM	Labcorp CFO Glenn Eisenberg Announces Plans to Retire (PR Newswire)
Nov-04-24 09:00AM	Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience (Business Wire)
Oct-30-24 01:02AM	Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight (GuruFocus.com)
12:58PM	Loading…
Oct-24-24 12:58PM	Analyst Report: Labcorp Holdings Inc. (Morningstar Research)
10:30AM	Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics (Zacks)
08:00AM	Labcorp (LH) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:58AM	Labcorp: Q3 Earnings Snapshot (Associated Press Finance)
06:50AM	Labcorp Announces 2024 Third Quarter Results (PR Newswire)
Oct-21-24 09:16AM	Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Oct-17-24 10:01AM	Labcorp (LH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-16-24 08:00AM	NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. (Business Wire)
Oct-10-24 08:30AM	Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test (PR Newswire)
06:50AM	Labcorp Declares Quarterly Dividend (PR Newswire)
09:34AM	Loading…
Oct-01-24 09:34AM	Meta, Alphabet initiated: Wall Street's top analyst calls (The Fly)
Sep-24-24 04:16PM	Labcorp to Announce Third Quarter Financial Results on October 24, 2024 (PR Newswire)
Sep-18-24 07:00AM	Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience (PR Newswire)
Sep-16-24 06:35PM	LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 (PR Newswire)
07:30AM	Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health (PR Newswire)
Sep-03-24 04:09PM	Labcorp to Speak at the Baird 2024 Global Healthcare Conference (PR Newswire)
Aug-27-24 07:05AM	Should You Invest in Labcorp Holdings (LH)? (Insider Monkey)
Aug-22-24 08:52AM	Should You Hold Labcorp (LH) Stock in Your Portfolio Now? (Zacks)
Aug-21-24 01:01PM	Insider Sale: EVP, Chief Legal Officer Sandra D van der Vaart Sells 2,000 Shares of Labcorp ... (GuruFocus.com)
Aug-19-24 01:01PM	Insider Sale: CFO Glenn Eisenberg Sells 15,000 Shares of Labcorp Holdings Inc (LH) (GuruFocus.com)
Aug-14-24 12:42PM	Labcorp (LH) Gains From New Collaborations Amid FX Issues (Zacks)
Aug-07-24 11:00AM	Insider Sale: EVP, CIO & CTO Lance Berberian Sells 12,093 Shares of Labcorp Holdings Inc (LH) (GuruFocus.com)
Aug-06-24 12:47AM	Labcorp wins FDA OK for pan-solid tumor liquid biopsy (MedTech Dive)
Aug-05-24 07:00AM	Labcorp Finalizes Acquisition of Select Assets of Invitae (PR Newswire)
04:12AM	FDA grants De Novo authorisation for Labcorps liquid biopsy test (Medical Device Network)
01:05AM	Loading…
Aug-03-24 01:05AM	Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight (GuruFocus.com)
Aug-02-24 01:12PM	Health Care Stock Soars Past Buy Point After Boosting Buyback (Investor's Business Daily)
08:30AM	Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx (PR Newswire)
06:31AM	Q2 2024 Labcorp Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-01-24 07:21PM	Analyst Report: Labcorp Holdings Inc. (Morningstar Research) +8.33%
03:02PM	Labcorp (LH) Q2 Earnings Surpass Estimates (revised) (Zacks)
01:31PM	LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector (Benzinga)
11:49AM	Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall (Investing.com)
09:47AM	Labcorp (LH) Q2 Earnings Surpass Estimates, Margins Increase (Zacks)
09:30AM	Compared to Estimates, Labcorp (LH) Q2 Earnings: A Look at Key Metrics (Zacks)
08:10AM	Labcorp (LH) Beats Q2 Earnings and Revenue Estimates (Zacks)
07:28AM	Labcorp beats Q2 profit and revenue estimates on demand for health tests (Reuters)
07:08AM	Labcorp: Q2 Earnings Snapshot (Associated Press Finance)
06:57AM	Labcorp Announces 2024 Second Quarter Results (PR Newswire)
Jul-31-24 06:00AM	Labcorp expands Ultima pact to boost genomic diagnostics (MedTech Dive)
Jul-30-24 07:00AM	Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities (PR Newswire)
Jul-25-24 10:02AM	Labcorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
06:59AM	Labcorp Declares Quarterly Dividend (PR Newswire)
Jul-22-24 09:27AM	Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release (Zacks)
Jul-12-24 08:36AM	Implied Volatility Surging for Labcorp (LH) Stock Options (Zacks)
Jul-09-24 10:00AM	Here's Why Labcorp (LH) is a Strong Value Stock (Zacks)
Jul-02-24 07:36AM	Is It the Right Time to Hold Labcorp (LH) in Your Portfolio? (Zacks)
Jul-01-24 07:00AM	Labcorp to Announce Second Quarter Financial Results on August 1, 2024 (PR Newswire)
Jun-20-24 02:20PM	Analyst Report: Labcorp Holdings Inc. (Morningstar Research)
Jun-18-24 06:53AM	Labcorp launches suite of laboratory solutions designed to expedite clinical trials (Clinical Trials Arena)
06:13AM	Ranking the top ten clinical research organisations in the world (Pharmaceutical Technology)
Jun-17-24 08:00AM	Labcorp Launches Global Trial Connect to Accelerate Clinical Trials (PR Newswire)
Jun-04-24 07:54AM	Labcorp Holdings (LH) is Trading at an Attractive Valuation (Insider Monkey)
07:32AM	Here's Why Diamond Hill Large Cap Strategy Sold BorgWarner (BWA) in Q1 (Insider Monkey)
Jun-03-24 07:00AM	Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio (PR Newswire)
May-30-24 07:00AM	Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting (PR Newswire)
May-28-24 06:59AM	Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference (PR Newswire)
May-21-24 09:40AM	Why Labcorp (LH) is a Top Value Stock for the Long-Term (Zacks)
May-16-24 11:00AM	Insider Sale: EVP, Chief Legal Officer van der Vaart Sandra D Sells Shares of Laboratory Corp ... (GuruFocus.com)
09:49AM	Labcorp (LH) to Assess Preeclampsia Risk With New Test (Zacks)
06:22AM	Labcorp launches first trimester preeclampsia screening test (Medical Device Network)
05:42AM	Baird Adjusts Price Target on Laboratory Corp of America Holdings to $256 From $255, Keeps Outperform Rating (MT Newswires)
May-15-24 08:00AM	Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy (PR Newswire)
May-09-24 10:41AM	Here's Why Investors Should Retain Labcorp (LH) Stock for Now (Zacks)
May-08-24 06:59AM	Labcorp to Webcast Its Annual Meeting of Shareholders (PR Newswire)
06:56AM	Q1 2024 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
03:44AM	OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ... (GuruFocus.com)
May-07-24 04:05PM	Invitae Receives Court Approval for Sale to Labcorp (PR Newswire)
May-02-24 02:22AM	Insider Sale at Laboratory Corp of America Holdings (LH) (GuruFocus.com)
May-01-24 01:03AM	Decoding Laboratory Corp of America Holdings (LH): A Strategic SWOT Insight (GuruFocus.com)
Apr-30-24 01:58PM	Laboratory Corporation of America Holdings (NYSE:LH) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:41AM	Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244 (MT Newswires)
Apr-29-24 10:17AM	Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy (MT Newswires)
07:00AM	Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B (PR Newswire)
Apr-26-24 11:14AM	Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255 (MT Newswires)
10:34AM	Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234 (MT Newswires)
07:55AM	Truist Cuts Price Target on Laboratory Corp of America Holdings to $255 From $270, Keeps Buy Rating (MT Newswires)
01:06AM	Q1 2024 Laboratory Corporation of America Holdings Earnings Call (Thomson Reuters StreetEvents)
Apr-25-24 01:41PM	Analyst Report: Laboratory Corporation of America Holdings (Morningstar Research)
01:11PM	Labcorp to acquire Invitaes assets for $239M (MedTech Dive)
12:45PM	Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating (MT Newswires)
10:18AM	Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View (Zacks)
09:30AM	Compared to Estimates, Labcorp (LH) Q1 Earnings: A Look at Key Metrics (Zacks)
09:22AM	Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated (MT Newswires)
08:35AM	Laboratory Corp of America Holdings (LH) Q1 Earnings: Surpasses Revenue Forecasts and Updates ... (GuruFocus.com)
07:09AM	Labcorp beats quarterly estimates on strong testing demand (Reuters)
07:06AM	Labcorp: Q1 Earnings Snapshot (Associated Press Finance)
06:58AM	Labcorp Announces 2024 First Quarter Results (PR Newswire)
Apr-24-24 10:25PM	Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 million (Reuters)
10:23PM	Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln (Reuters)
09:27PM	Labcorp Announces Winning Bid for Select Assets of Invitae (PR Newswire)
09:19PM	Invitae Enters into Agreement with Labcorp for Sale of Business (PR Newswire)
Apr-22-24 09:16AM	Exploring Analyst Estimates for Labcorp (LH) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Apr-19-24 05:34AM	Labcorp (LH) Expected to Beat Earnings Estimates: Should You Buy? (Revised) (Zacks)
Apr-18-24 12:10PM	Why Labcorp (LH) Could Beat Earnings Estimates Again (Zacks)

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EISENBERG GLENN A	Executive Vice President	Dec 02 '24	Option Exercise	212.21	11,711	2,485,154	43,000	Dec 04 09:59 AM
EISENBERG GLENN A	Executive Vice President	Dec 02 '24	Sale	240.43	11,711	2,815,651	31,289	Dec 04 09:59 AM
Gilliland Dwight Gary	Director	Dec 02 '24	Sale	241.00	1,000	241,000	7,712	Dec 04 09:55 AM
EISENBERG GLENN A	Officer	Dec 02 '24	Proposed Sale	240.43	11,711	2,815,651		Dec 02 04:15 PM
Gilliland Dwight Gary	Director	Dec 02 '24	Proposed Sale	241.00	1,000	241,000		Dec 02 03:36 PM
Summy Amy B.	EVP, Chief Marketing Officer	Nov 22 '24	Option Exercise	168.52	4,015	676,608	7,990	Nov 26 11:06 AM
Summy Amy B.	EVP, Chief Marketing Officer	Nov 22 '24	Sale	238.91	3,672	877,142	4,318	Nov 26 11:06 AM
van der Vaart Sandra D	EVP, Chief Legal Officer	Nov 21 '24	Sale	239.42	1,000	239,419	2,670	Nov 25 08:14 AM
Summy Amy B.	Officer	Nov 22 '24	Proposed Sale	238.87	3,672	877,142		Nov 22 04:56 PM
van der Vaart Sandra D	Officer	Nov 21 '24	Proposed Sale	239.42	1,000	239,419		Nov 21 03:20 PM
Schechter Adam H	President & CEO	Nov 11 '24	Sale	243.47	6,189	1,506,836	87,441	Nov 13 08:16 AM
Schechter Adam H	Officer	Nov 11 '24	Proposed Sale	243.47	6,189	1,506,836		Nov 12 08:44 AM
ANDERSON KERRII B	Director	Oct 24 '24	Sale	230.00	1,000	230,000	13,722	Oct 25 09:26 AM
KERRII B ANDERSON	Director	Oct 24 '24	Proposed Sale	219.90	1,000	219,900		Oct 24 04:21 PM
DiVincenzo Jonathan P.	Officer	Sep 03 '24	Proposed Sale	229.66	5,460	1,253,956		Sep 03 02:23 PM
van der Vaart Sandra D	EVP, Chief Legal Officer	Aug 19 '24	Sale	227.05	2,000	454,100	3,670	Aug 21 09:08 AM
van der Vaart Sandra D	Officer	Aug 19 '24	Proposed Sale	227.05	2,000	454,100		Aug 19 11:44 AM
EISENBERG GLENN A	Chief Financial Officer, EVP	Aug 15 '24	Sale	223.99	15,000	3,359,825	31,289	Aug 19 10:22 AM
EISENBERG GLENN A	Officer	Aug 15 '24	Proposed Sale	223.99	15,000	3,359,825		Aug 15 06:02 PM
ANDERSON KERRII B	Director	Aug 08 '24	Sale	225.00	586	131,850	14,722	Aug 09 10:16 AM
ANDERSON KERRII B	Director	Aug 07 '24	Sale	225.00	414	93,150	15,308	Aug 09 10:16 AM
KERRII B ANDERSON	Director	Aug 07 '24	Proposed Sale	225.87	1,000	225,870		Aug 07 04:12 PM
BERBERIAN LANCE	EVP, CIO & CTO	Aug 05 '24	Sale	229.10	12,093	2,770,552	15,921	Aug 07 08:47 AM
BERBERIAN LANCE	Officer	Aug 05 '24	Proposed Sale	229.10	12,093	2,770,554		Aug 05 05:13 PM
van der Vaart Sandra D	EVP, Chief Legal Officer	May 14 '24	Sale	210.83	2,000	421,655	5,637	May 16 08:02 AM
ANDERSON KERRII B	Director	Apr 30 '24	Sale	204.13	250	51,034	15,972	May 02 04:29 PM
ANDERSON KERRII B	Director	May 02 '24	Sale	200.10	250	50,025	15,722	May 02 04:29 PM
Wilkinson Peter J	SVP, Chief Accounting Officer	Apr 29 '24	Sale	204.33	2,439	498,358	2,087	May 01 06:29 PM
Schroeder Mark S	EVP, Pres Diagnostics & COO	Apr 01 '24	Sale	217.29	6,477	1,407,387	5,036	Apr 03 08:35 AM
Summy Amy B.	EVP, Chief Marketing Officer	Apr 01 '24	Sale	217.29	3,500	760,515	3,975	Apr 03 08:34 AM
van der Vaart Sandra D	EVP, Chief Legal Officer	Mar 28 '24	Sale	216.74	3,553	770,077	7,637	Mar 29 05:54 PM
Schroeder Mark S	EVP, Pres Diagnostics & COO	Mar 07 '24	Option Exercise	117.09	2,119	248,114	10,084	Mar 11 08:59 AM
Schroeder Mark S	EVP, Pres Diagnostics & COO	Mar 07 '24	Sale	218.45	5,048	1,102,736	5,036	Mar 11 08:59 AM
Summy Amy B.	EVP, Chief Marketing Officer	Mar 07 '24	Sale	218.45	227	49,588	3,859	Mar 11 08:56 AM
EISENBERG GLENN A	Chief Financial Officer, EVP	Feb 21 '24	Option Exercise	163.63	14,054	2,299,656	58,099	Feb 22 03:05 PM
EISENBERG GLENN A	Chief Financial Officer, EVP	Feb 21 '24	Sale	215.97	34,504	7,451,866	23,595	Feb 22 03:05 PM
DiVincenzo Jonathan P.	EVP, Pres, Central Labs & Intl	Feb 21 '24	Sale	215.49	500	107,745	3,401	Feb 22 03:04 PM
van der Vaart Sandra D	EVP, Chief Legal Officer	Feb 13 '24	Sale	226.45	237	53,669	7,637	Feb 15 08:32 AM
van der Vaart Sandra D	EVP, Chief Legal Officer	Feb 08 '24	Sale	222.06	259	57,514	7,637	Feb 09 12:19 PM
van der Vaart Sandra D	EVP, Chief Legal Officer	Feb 05 '24	Sale	220.57	193	42,570	7,637	Feb 06 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LH

Labcorp Holdings Inc

Upgrade your FINVIZ experience